白蛋白-话题@MedSci

#白蛋白#

167篇内容 | 4278人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1304696, encodeId=e9fb130469669, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Lancet Diabetes Endocrinol：达格列净对伴有和不伴有2型糖尿病的慢性肾病患者尿白蛋白排泄的影响, objectType=article, longId=219381, objectId=e9092193818b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9092193818b, replyNumber=0, likeNumber=89, createdTime=2021-10-29, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9092193818b, moduleTitle=Lancet Diabetes Endocrinol：达格列净对伴有和不伴有2型糖尿病的慢性肾病患者尿白蛋白排泄的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9092193818b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304695, encodeId=f1ed130469531, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Br J Cancer：基于白蛋白胆红素（ALBI）分级评估卡博替尼（cabozantinib）治疗晚期肝细胞癌（HCC）的疗效和安全性, objectType=article, longId=218274, objectId=25462182e412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25462182e412, replyNumber=0, likeNumber=65, createdTime=2021-10-10, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25462182e412, moduleTitle=Br J Cancer：基于白蛋白胆红素（ALBI）分级评估卡博替尼（cabozantinib）治疗晚期肝细胞癌（HCC）的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25462182e412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304694, encodeId=e993130469461, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=JCC: 低白蛋白血症与接受回结肠切除术的克罗恩病患者的术后并发症发生有关, objectType=article, longId=214229, objectId=7cf821422947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cf821422947, replyNumber=0, likeNumber=86, createdTime=2021-07-16, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cf821422947, moduleTitle=JCC: 低白蛋白血症与接受回结肠切除术的克罗恩病患者的术后并发症发生有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cf821422947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304693, encodeId=cee513046936e, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Ann Oncol: atezolizumab联合白蛋白结合型紫杉醇一线治疗不可切除、局部晚期或转移性三阴性乳腺癌的疗效: IMpassion130最终总生存分析, objectType=article, longId=213736, objectId=41a6213e36ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41a6213e36ec, replyNumber=0, likeNumber=125, createdTime=2021-07-06, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41a6213e36ec, moduleTitle=Ann Oncol: atezolizumab联合白蛋白结合型紫杉醇一线治疗不可切除、局部晚期或转移性三阴性乳腺癌的疗效: IMpassion130最终总生存分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41a6213e36ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304692, encodeId=614413046922a, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=BMC Gastroenterology:术前前白蛋白水平低可预测肝移植术后并发症的发生率, objectType=article, longId=211725, objectId=1012211e25f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1012211e25f4, replyNumber=0, likeNumber=75, createdTime=2021-05-25, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1012211e25f4, moduleTitle=BMC Gastroenterology:术前前白蛋白水平低可预测肝移植术后并发症的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1012211e25f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304691, encodeId=7d49130469153, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, objectType=article, longId=211429, objectId=be23211429df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be23211429df, replyNumber=0, likeNumber=72, createdTime=2021-05-18, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be23211429df, moduleTitle=Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be23211429df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304690, encodeId=e7081304690ec, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Eur J Cancer：吉西他滨+白蛋白结合型紫杉醇对比FOLFIRINOX一线治疗晚期胰腺癌疗效和安全性, objectType=article, longId=211073, objectId=73fa2110e321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73fa2110e321, replyNumber=0, likeNumber=84, createdTime=2021-05-12, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73fa2110e321, moduleTitle=Eur J Cancer：吉西他滨+白蛋白结合型紫杉醇对比FOLFIRINOX一线治疗晚期胰腺癌疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73fa2110e321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304689, encodeId=fd921304689ec, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后, objectType=article, longId=211025, objectId=13fb211025c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13fb211025c6, replyNumber=0, likeNumber=70, createdTime=2021-05-11, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13fb211025c6, moduleTitle=Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13fb211025c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304687, encodeId=aa6f130468eac, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=JGH: 肝硬化和肝腹水患者长期服用白蛋白利大于弊, objectType=article, longId=210214, objectId=9dd12102149f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dd12102149f, replyNumber=0, likeNumber=83, createdTime=2021-04-21, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dd12102149f, moduleTitle=JGH: 肝硬化和肝腹水患者长期服用白蛋白利大于弊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dd12102149f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304688, encodeId=1ab21304688fc, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=为什么人血白蛋白不能输注太快？, objectType=article, longId=210034, objectId=827221003494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=827221003494, replyNumber=0, likeNumber=83, createdTime=2021-04-17, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=827221003494, moduleTitle=为什么人血白蛋白不能输注太快？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=827221003494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304686, encodeId=883e130468627, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Journal of Anesthesia：肝脏及胰腺手术中比较6%羟乙基淀粉130/0.4/9和5%白蛋白安全性、容积有效性和糖萼降解影响的开放随机试验, objectType=article, longId=210025, objectId=c8042100255e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8042100255e, replyNumber=0, likeNumber=128, createdTime=2021-04-17, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8042100255e, moduleTitle=Journal of Anesthesia：肝脏及胰腺手术中比较6%羟乙基淀粉130/0.4/9和5%白蛋白安全性、容积有效性和糖萼降解影响的开放随机试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8042100255e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304685, encodeId=0a4d1304685e8, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=NEJM：特利加压素联合白蛋白治疗1型肝肾综合征, objectType=article, longId=208183, objectId=5b2d208183e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b2d208183e4, replyNumber=0, likeNumber=76, createdTime=2021-03-10, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b2d208183e4, moduleTitle=NEJM：特利加压素联合白蛋白治疗1型肝肾综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b2d208183e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304684, encodeId=35bd13046843e, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=NEJM：风风雨雨70年，白蛋白输注治疗肝硬化的地位将被改写！, objectType=article, longId=208176, objectId=c46f2081e614, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c46f2081e614, replyNumber=0, likeNumber=58, createdTime=2021-03-10, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c46f2081e614, moduleTitle=NEJM：风风雨雨70年，白蛋白输注治疗肝硬化的地位将被改写！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c46f2081e614)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304683, encodeId=17f01304683af, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=NEJM：白蛋白输注对肝硬化患者的作用, objectType=article, longId=207908, objectId=361320e908f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=361320e908f3, replyNumber=0, likeNumber=64, createdTime=2021-03-07, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=361320e908f3, moduleTitle=NEJM：白蛋白输注对肝硬化患者的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=361320e908f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304682, encodeId=9e7f1304682c8, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Dig Dis Sci：低白蛋白和低血红蛋白可以预测英夫利昔单抗在治疗急性重症溃疡性结肠炎患者中的失败概率, objectType=article, longId=205749, objectId=970c205e496a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=970c205e496a, replyNumber=0, likeNumber=57, createdTime=2021-01-16, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=970c205e496a, moduleTitle=Dig Dis Sci：低白蛋白和低血红蛋白可以预测英夫利昔单抗在治疗急性重症溃疡性结肠炎患者中的失败概率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=970c205e496a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304681, encodeId=715e130468153, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Crit Care：输注白蛋白可预防透析间低血压, objectType=article, longId=205479, objectId=04772054e951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04772054e951, replyNumber=0, likeNumber=78, createdTime=2021-01-09, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04772054e951, moduleTitle=Crit Care：输注白蛋白可预防透析间低血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04772054e951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304680, encodeId=0b1d130468039, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=患者招募：Pamrevlumab或安慰剂联合吉西他滨/白蛋白紫杉醇（G/N）作为新辅助治疗用于局部晚期不可切除胰腺癌：一项III期、随机、双盲研究, objectType=article, longId=204949, objectId=3e49204949d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e49204949d8, replyNumber=0, likeNumber=35, createdTime=2020-12-30, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e49204949d8, moduleTitle=患者招募：Pamrevlumab或安慰剂联合吉西他滨/白蛋白紫杉醇（G/N）作为新辅助治疗用于局部晚期不可切除胰腺癌：一项III期、随机、双盲研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e49204949d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304679, encodeId=aa0c13046e9b4, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=IBD：血清白蛋白的早期变化可预测溃疡性结肠炎患者开始抗TNF治疗的临床和内镜结果, objectType=article, longId=204205, objectId=943d2042052f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=943d2042052f, replyNumber=0, likeNumber=65, createdTime=2020-12-08, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=943d2042052f, moduleTitle=IBD：血清白蛋白的早期变化可预测溃疡性结肠炎患者开始抗TNF治疗的临床和内镜结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=943d2042052f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304678, encodeId=c76f13046e83c, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势, objectType=article, longId=203492, objectId=e99720349246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e99720349246, replyNumber=0, likeNumber=121, createdTime=2020-11-18, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e99720349246, moduleTitle=Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e99720349246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1304677, encodeId=b83d13046e708, content=<a href='/topic/show?id=cd37e1767b5' target=_blank style='color:#2F92EE;'>#白蛋白#</a>, objectTitle=T药+白蛋白紫杉醇一线治疗三阴乳腺癌：PD-L1阳性人群OS获益显著，亚洲人群不佳, objectType=article, longId=201088, objectId=5c682010884c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c682010884c, replyNumber=0, likeNumber=75, createdTime=2020-09-24, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c682010884c, moduleTitle=T药+白蛋白紫杉醇一线治疗三阴乳腺癌：PD-L1阳性人群OS获益显著，亚洲人群不佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c682010884c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

白蛋白

2020-05-29

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Lancet Diabetes Endocrinol：达格列净对伴有和不伴有2型糖尿病的慢性肾病患者尿白蛋白排泄的影响

2021-10-29

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Br J Cancer：基于白蛋白胆红素（ALBI）分级评估卡博替尼（cabozantinib）治疗晚期肝细胞癌（HCC）的疗效和安全性

2021-10-10

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

JCC: 低白蛋白血症与接受回结肠切除术的克罗恩病患者的术后并发症发生有关

2021-07-16

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Ann Oncol: atezolizumab联合白蛋白结合型紫杉醇一线治疗不可切除、局部晚期或转移性三阴性乳腺癌的疗效: IMpassion130最终总生存分析

2021-07-06

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

BMC Gastroenterology:术前前白蛋白水平低可预测肝移植术后并发症的发生率

2021-05-25

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Hepatology：肝肾综合征患者对特利加压素和白蛋白的反应与肝移植的预后改善相关

2021-05-18

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Eur J Cancer：吉西他滨+白蛋白结合型紫杉醇对比FOLFIRINOX一线治疗晚期胰腺癌疗效和安全性

2021-05-12

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Clinical Nutrition: 白蛋白-球蛋白评分和骨骼肌指数的组合可以有效预测肝内胆管癌手术患者的预后

2021-05-11

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

JGH: 肝硬化和肝腹水患者长期服用白蛋白利大于弊

2021-04-21

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

为什么人血白蛋白不能输注太快？

2021-04-17

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Journal of Anesthesia：肝脏及胰腺手术中比较6%羟乙基淀粉130/0.4/9和5%白蛋白安全性、容积有效性和糖萼降解影响的开放随机试验

2021-04-17

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

NEJM：特利加压素联合白蛋白治疗1型肝肾综合征

2021-03-10

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

NEJM：风风雨雨70年，白蛋白输注治疗肝硬化的地位将被改写！

2021-03-10

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

NEJM：白蛋白输注对肝硬化患者的作用

2021-03-07

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Dig Dis Sci：低白蛋白和低血红蛋白可以预测英夫利昔单抗在治疗急性重症溃疡性结肠炎患者中的失败概率

2021-01-16

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Crit Care：输注白蛋白可预防透析间低血压

2021-01-09

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

患者招募：Pamrevlumab或安慰剂联合吉西他滨/白蛋白紫杉醇（G/N）作为新辅助治疗用于局部晚期不可切除胰腺癌：一项III期、随机、双盲研究

2020-12-30

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

IBD：血清白蛋白的早期变化可预测溃疡性结肠炎患者开始抗TNF治疗的临床和内镜结果

2020-12-08

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势

2020-11-18

珙桐 (审核中...)

前往app查看评论内容

#白蛋白#

T药+白蛋白紫杉醇一线治疗三阴乳腺癌：PD-L1阳性人群OS获益显著，亚洲人群不佳

2020-09-24

科室
- - 订阅+
  - 更多科室
工具
服务